Targeted Nano Therapeutics, LLC (“TNT Pharma” or the “Company”) is a dynamic, emerging pharmaceutical company focused on the development of improved injectable and novel, oral delivery of proteins, peptides and large molecule therapeutics utilizing the Company’s proprietary cell-targeted, bio-nanotechnology-based system called NanoVes®. TNT Pharma and its partners have been advancing the development of the NanoVes System for over five years.

TNT Pharma has demonstrated proof of concept of its lead product in a human clinical trial, optimized its formulation, established manufacturing under GMP controls and has scaled up to be able to manufacture large batches in a cost effective manner.